Home
Chase & Co Jpmorgan reported a 4.8% stake in Cartesian Therapeutics RNAC · 1,486,252 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.8%
- Last report
- 6.1% · filed 25/04/25
- Shares held
- 1,486,252 sh
- Class
- Common Stock, $0.0001 par value per share
- Holder
- Chase & Co Jpmorgan
- Event date
- 26/06/30
- Filed
- 26/07/22
4.8% stake · below 5%
- Stake
- 4.8%
- Last report
- 6.1%
- Since last report
- −1.3pp
Cartesian Therapeutics trades, last 26 weeks
What else happened in Cartesian Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Chase & Co Jpmorgan's other 5% stake reports
- Chase & Co Jpmorgan
5% stakeBlackrock Muniholdings Fund
5% stakeBlackrock Muniholdings Fund
MHD
100% stake
7,178 sh
100% stake
Filed 10/01
- Chase & Co Jpmorgan
5% stakeCiena
5% stakeCiena
CIEN
3.9% stake
5,616,378 sh
3.9% stake
Filed 09/03
- Chase & Co Jpmorgan
5% stakeVicor
5% stakeVicor
VICR
4% stake
1,394,339 sh
4% stake
Filed 09/03
- Chase & Co Jpmorgan
5% stakeMKS
5% stakeMKS
MKSI
2.9% stake
2,005,756 sh
2.9% stake
Filed 09/03
- Chase & Co Jpmorgan
5% stakeLamb Weston Holdings
5% stakeLamb Weston Holdings
LW
4.9% stake
6,889,942 sh
4.9% stake
Filed 08/05
